We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

ICU Medical Inc (ICUI) Com Stk USD0.10

Sell:$50.39 Buy:$201.53 Change: $2.25 (1.75%)
Market closed |  Prices as at close on 12 July 2024 | Switch to live prices |
Change: $2.25 (1.75%)
Market closed |  Prices as at close on 12 July 2024 | Switch to live prices |
Change: $2.25 (1.75%)
Market closed |  Prices as at close on 12 July 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needle free IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy product include Portex BLUselect PVC tracheostomy tubes.

Contact details

951 Calle Amanecer
United States
+1 (949) 3662183

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$3.00 billion
Shares in issue:
24.37 million
Health Care Supplies
United States
US dollar
NASDAQ Comb. Composite

Key personnel

  • Vivek Jain
    Chairman of the Board, Chief Executive Officer
  • Brian Bonnell
    Chief Financial Officer, Treasurer
  • Christian Voigtlander
    Chief Operating Officer
  • Virginia Sanzone
    Corporate Vice President, General Counsel, Secretary
  • Daniel Woolson
    Corporate Vice President, General Manager - Infusion Systems

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.